Table 3 |
|||
|
Antibiotic resistance profiles of 506 Community acquired and 68 Nosocomial isolates, as determined by disk diffusion. |
|||
| Community acquired |
Nosocomial infection |
||
| Resistance rate (%) |
Resistance rate (%) |
P |
|
|
|
|||
| Penicillin |
87.9 |
91.2 |
0.43 |
| Oxacillin |
6.5 |
4.4 |
0.50 |
| Erythromycin |
14.6 |
10.3 |
0.43 |
| Lincomycin |
6.1 |
7.3 |
0.51 |
| Pristinamycin |
0.4 |
0.0 |
0.56 |
| Kanamycin |
7.3 |
8.8 |
0.65 |
| Tobramycin |
4.5 |
4.4 |
0.96 |
| Gentamicin |
1.9 |
0 |
- |
| Ciprofloxacin |
5.5 |
8.8 |
0.30 |
| Tetracyclin |
56.5 |
51.4 |
0.43 |
| Minocyclin |
15.8 |
2.9 |
<0.01 |
| Trimethoprim sulfamethoxazole |
16.8 |
13.2 |
0.44 |
| Rifampicin |
4.1 |
7.3 |
0.25 |
| Fusidic acid |
8.9 |
10.3 |
0.70 |
| Chloramphenicol |
10.1 |
11.7 |
0.66 |
| Fosfomycin |
1.6 |
1.5 |
0.94 |
| Vancomycin |
0 |
0 |
- |
| Teicoplanin |
0 |
0 |
- |
|
|
|||
| Multiresistant |
1.58 |
0 |
- |
Randrianirina et al. Annals of Clinical Microbiology and Antimicrobials 2007 6:5 doi:10.1186/1476-0711-6-5 |
|||
